Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Hematology (Internal Medicine) Physician in Columbus, OH
NPI: 1154595049Primary Practice Location
OHIO STATE UNIVERSITY STATE HEALTH SYSTEM
1670 Upham Dr, Columbus, OH
Primary Employer
OSU Internal Medicine
wexnermedical.osu.edu
HQ Phone
Get M.D Srinivas's Phone Numberphone_androidMobile
Get M.D Srinivas's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardOH State Medical License
LA State Medical License
LA State Medical License
2009
OH State Medical License
2018 - 2027
PA State Medical License
2005 - 2018
MA State Medical License
2008 - 2011
American Board of Internal Medicine
Hematology
American Board of Internal Medicine
Medical Oncology
Louisiana State University School of Medicine
Fellowship • Hematology and Medical Oncology
2011 - 2014
Robert Packer Hospital/Guthrie
Residency • Internal Medicine
2005 - 2008
Osmania Medical College NTR UHS
Medical School
Until 2003
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 130 | 160 |
| 2 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 44 | 137 |
| 3 | 99223Initial hospital inpatient care, typically 70 minutes per day | 21 | 21 |
Authors: Jason Prosek, Kiran Kandukurti
Journal: Clin Nephrol
Authors: Nidhi Sharma, Ashley Rosko, Yvonne Efebera, Don Benson, Naresh Bumma
Journal: J Clin Med
Publication Date: 2020-11-11
NCCN Guidelines® Insights: Multiple Myeloma, Version 1.2025.
Authors: Carol Huff, Kehinde Adekola, Rachid Baz, Michaela Liedtke, Thomas Martin, Malin Hultcrantz, Mark Schroeder, Timothy Robinson, Yubin Kang, Kelly Godby, James Omel, Shaji Kumar, Daniel Sherbenou, Jason Valent, Asya Nina Varshavsky Yanovsky, Natalie Callander, Amandeep Godara, Aaron Rosenberg, Caitlin Costello, Attaya Suvannasankha,
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Dexamethasone, DRUG: Carfilzomib, DRUG: Telaglenastat Hydrochloride
Lead Sponsor: Srinivas Devarakonda
Intervention / Treatment: DRUG: Cyclophosphamide, DRUG: Melphalan, DRUG: Tacrolimus, BIOLOGICAL: Daratumumab, DRUG: Mycophenolate Mofetil, DRUG: Fludarabine, PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation
Lead Sponsor: NexImmune Inc.
Intervention / Treatment: BIOLOGICAL: Infusion of NEXI-001 T Cells
